Skip to main content
Erschienen in: Journal of Neurology 12/2012

01.12.2012 | Original Communication

A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome

verfasst von: Lubov Blumkin, Sara Kivity, Dorit Lev, Sarit Cohen, Ruth Shomrat, Tally Lerman-Sagie, Esther Leshinsky-Silver

Erschienen in: Journal of Neurology | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Mutations in the potassium channel-related gene KCTD7 were described so far in a single family with progressive myoclonus epilepsy. We describe a unique phenotype: acute onset of myoclonus and ataxia, associated with abnormal opsoclonus-like eye movements; improvement of clinical symptoms under steroid treatment; and appearance of epileptic activity on EEG 2 years later without overt seizures. After excluding possible genetic causes, whole-genome exome sequencing was performed in order to identify the causative gene. One heterozygous missense mutation (R84W) was detected by exome sequencing and a large heterozygous deletion of exons 3 and 4 by MLPA analysis. The father is heterozygous for the R84W mutation and the mother is heterozygous for the exon 3+4 deletion. The mutation affects a highly conserved segment of the predicted protein, changing a basic amino acid into neutral. The large deletion probably results in a truncated protein. The different phenotype broadens the spectrum of KCTD7-related diseases. Therefore, patients diagnosed as having opsoclonus-myoclonus with an atypical course should be evaluated for KCTD7 mutations.
Literatur
1.
Zurück zum Zitat Kinsbourne M (1962) Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiat 25:271–276PubMedCrossRef Kinsbourne M (1962) Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiat 25:271–276PubMedCrossRef
2.
Zurück zum Zitat Pranzatelli MR, Chun KY, Moxness M, Tate ED, Allison TJ (2005) Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy. Pediatr Neurol 33:121–126PubMedCrossRef Pranzatelli MR, Chun KY, Moxness M, Tate ED, Allison TJ (2005) Cerebrospinal fluid ACTH and cortisol in opsoclonus-myoclonus: effect of therapy. Pediatr Neurol 33:121–126PubMedCrossRef
3.
Zurück zum Zitat Ramachandran N, Girard JM, Turnbull J, Minassian BA (2009) The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 50(Suppl 5):29–36PubMedCrossRef Ramachandran N, Girard JM, Turnbull J, Minassian BA (2009) The autosomal recessively inherited progressive myoclonus epilepsies and their genes. Epilepsia 50(Suppl 5):29–36PubMedCrossRef
4.
Zurück zum Zitat Bassuk AG, Wallace RH, Buhr A, Buller AR, Afawi Z, Shimojo M, Miyata S, Chen S, Gonzalez-Alegre P, Griesbach HL, Wu S, Nashelsky M, Vladar EK, Antic D, Ferguson PJ, Cirak S, Voit T, Scott MP, Axelrod JD, Gurnett C, Daoud AS, Kivity S, Neufeld MY, Mazarib A, Straussberg R, Walid S, Korczyn AD, Slusarski DC, Berkovic SF, El-Shanti HI (2008) A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy–ataxia syndrome. Am J Hum Genet 83:572–581PubMedCrossRef Bassuk AG, Wallace RH, Buhr A, Buller AR, Afawi Z, Shimojo M, Miyata S, Chen S, Gonzalez-Alegre P, Griesbach HL, Wu S, Nashelsky M, Vladar EK, Antic D, Ferguson PJ, Cirak S, Voit T, Scott MP, Axelrod JD, Gurnett C, Daoud AS, Kivity S, Neufeld MY, Mazarib A, Straussberg R, Walid S, Korczyn AD, Slusarski DC, Berkovic SF, El-Shanti HI (2008) A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy–ataxia syndrome. Am J Hum Genet 83:572–581PubMedCrossRef
5.
Zurück zum Zitat Van Bogaert P, Azizieh R, Désir J, Aeby A, De Meirleir L, Laes JF, Christiaens F, Abramowicz MJ (2007) Mutation of a potassium channel-related gene in progressive myoclonic epilepsy. Ann Neurol 61:579–586PubMedCrossRef Van Bogaert P, Azizieh R, Désir J, Aeby A, De Meirleir L, Laes JF, Christiaens F, Abramowicz MJ (2007) Mutation of a potassium channel-related gene in progressive myoclonic epilepsy. Ann Neurol 61:579–586PubMedCrossRef
6.
Zurück zum Zitat Dibbens LM, Michelucci R, Gambardella A, Andermann F, Rubboli G, Bayly MA, Joensuu T, Vears DF, Franceschetti S, Canafoglia L, Wallace R, Bassuk AG, Power DA, Tassinari CA, Andermann E, Lehesjoki AE, Berkovic SF (2009) SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Ann Neurol 66:532–536PubMedCrossRef Dibbens LM, Michelucci R, Gambardella A, Andermann F, Rubboli G, Bayly MA, Joensuu T, Vears DF, Franceschetti S, Canafoglia L, Wallace R, Bassuk AG, Power DA, Tassinari CA, Andermann E, Lehesjoki AE, Berkovic SF (2009) SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure. Ann Neurol 66:532–536PubMedCrossRef
7.
Zurück zum Zitat Pérez-Dueñas B, Toma C, Ormazábal A, Muchart J, Sanmartí F, Bombau G, Serrano M, García-Cazorla A, Cormand B, Artuch R (2010) Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene. J Inherit Metab Dis 33:795–802PubMedCrossRef Pérez-Dueñas B, Toma C, Ormazábal A, Muchart J, Sanmartí F, Bombau G, Serrano M, García-Cazorla A, Cormand B, Artuch R (2010) Progressive ataxia and myoclonic epilepsy in a patient with a homozygous mutation in the FOLR1 gene. J Inherit Metab Dis 33:795–802PubMedCrossRef
8.
Zurück zum Zitat Corbett MA, Schwake M, Bahlo M, Dibbens LM, Lin M, Gandolfo LC, Vears DF, O’Sullivan JD, Robertson T, Bayly MA, Gardner AE, Vlaar AM, Korenke GC, Bloem BR, de Coo IF, Verhagen JMA, Lehesjoki A-E, Gecz J, Berkovic SF (2011) A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia. Am J Hum Genet 88:657–663PubMedCrossRef Corbett MA, Schwake M, Bahlo M, Dibbens LM, Lin M, Gandolfo LC, Vears DF, O’Sullivan JD, Robertson T, Bayly MA, Gardner AE, Vlaar AM, Korenke GC, Bloem BR, de Coo IF, Verhagen JMA, Lehesjoki A-E, Gecz J, Berkovic SF (2011) A mutation in the Golgi Qb-SNARE gene GOSR2 causes progressive myoclonus epilepsy with early ataxia. Am J Hum Genet 88:657–663PubMedCrossRef
9.
Zurück zum Zitat Matthay KK, Blaes F, Hero B, Plantaz D, De Alarcon P, Mitchell WG, Pike M, Pistoia V (2005) Opsoclonus myoclonus syndrome in neuroblastoma: a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy. Cancer Lett 228:275–282PubMedCrossRef Matthay KK, Blaes F, Hero B, Plantaz D, De Alarcon P, Mitchell WG, Pike M, Pistoia V (2005) Opsoclonus myoclonus syndrome in neuroblastoma: a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy. Cancer Lett 228:275–282PubMedCrossRef
10.
Zurück zum Zitat Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Verhulst SJ (2004) CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Mov Disord 19:770–777PubMedCrossRef Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Verhulst SJ (2004) CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Mov Disord 19:770–777PubMedCrossRef
11.
Zurück zum Zitat Gorman MP (2010) Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome. Curr Opin Pediatr 22:745–750PubMedCrossRef Gorman MP (2010) Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome. Curr Opin Pediatr 22:745–750PubMedCrossRef
12.
Zurück zum Zitat Shahwan A, Farrell M, Delanty N (2005) Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 4:239–248PubMedCrossRef Shahwan A, Farrell M, Delanty N (2005) Progressive myoclonic epilepsies: a review of genetic and therapeutic aspects. Lancet Neurol 4:239–248PubMedCrossRef
13.
Zurück zum Zitat Pranzatelli MR (1992) The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 15:186–228PubMedCrossRef Pranzatelli MR (1992) The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 15:186–228PubMedCrossRef
14.
Zurück zum Zitat Haden SV, McShane MA, Holt CM (2009) Opsoclonus myoclonus: a non-epileptic movement disorder that may present as status epilepticus. Arch Dis Child 94:897–899PubMedCrossRef Haden SV, McShane MA, Holt CM (2009) Opsoclonus myoclonus: a non-epileptic movement disorder that may present as status epilepticus. Arch Dis Child 94:897–899PubMedCrossRef
15.
Zurück zum Zitat Rubboli G, Franceschetti S, Berkovic SF, Canafoglia L, Gambardella A, Dibbens LM, Riguzzi P, Campieri C, Magaudda A, Tassinari CA, Michelucci R (2011) Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCA. Epilepsia 52:2356–2363PubMedCrossRef Rubboli G, Franceschetti S, Berkovic SF, Canafoglia L, Gambardella A, Dibbens LM, Riguzzi P, Campieri C, Magaudda A, Tassinari CA, Michelucci R (2011) Clinical and neurophysiologic features of progressive myoclonus epilepsy without renal failure caused by SCA. Epilepsia 52:2356–2363PubMedCrossRef
16.
Zurück zum Zitat Herman TE, Siegel MJ (2009) Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma. Clin Pediatr 48:336–340CrossRef Herman TE, Siegel MJ (2009) Ataxia without opsoclonus: right lumbar sympathetic trunk neuroblastoma. Clin Pediatr 48:336–340CrossRef
17.
Zurück zum Zitat de Haan GJ, Pinto D, Carton D, Bader A, Witte J, Peters E, van Erp G, Vandereyken W, Boezeman E, Wapenaar MC, Boon P, Halley D, Koeleman BP, Lindhout D (2006) A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years. Epilepsia 47:851–889PubMedCrossRef de Haan GJ, Pinto D, Carton D, Bader A, Witte J, Peters E, van Erp G, Vandereyken W, Boezeman E, Wapenaar MC, Boon P, Halley D, Koeleman BP, Lindhout D (2006) A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years. Epilepsia 47:851–889PubMedCrossRef
18.
19.
Zurück zum Zitat Azizieh R, Orduz D, Van Bogaert P, Bouschet T, Rodriguez W, Schiffmann SN, Pirson I, Abramowicz MJ (2011) Progressive myoclonic epilepsy-associated gene KCTD7 is a regulator of potassium conductance in neurons. Mol Neurobiol 44:111–121PubMedCrossRef Azizieh R, Orduz D, Van Bogaert P, Bouschet T, Rodriguez W, Schiffmann SN, Pirson I, Abramowicz MJ (2011) Progressive myoclonic epilepsy-associated gene KCTD7 is a regulator of potassium conductance in neurons. Mol Neurobiol 44:111–121PubMedCrossRef
Metadaten
Titel
A compound heterozygous missense mutation and a large deletion in the KCTD7 gene presenting as an opsoclonus-myoclonus ataxia-like syndrome
verfasst von
Lubov Blumkin
Sara Kivity
Dorit Lev
Sarit Cohen
Ruth Shomrat
Tally Lerman-Sagie
Esther Leshinsky-Silver
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Journal of Neurology / Ausgabe 12/2012
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-012-6545-z

Weitere Artikel der Ausgabe 12/2012

Journal of Neurology 12/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.